Perioperative Anticoagulant Use for Surgery Evaluation Study

CompletedOBSERVATIONAL
Enrollment

3,135

Participants

Timeline

Start Date

August 1, 2014

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Atrial Fibrillation
Trial Locations (21)

48202

Henry Ford Health System, Detroit

60201

NorthShore University HealthSystem, Evanston

Unknown

Department of Pharmacy, Kaiser Permanente Colorado, Aurora, CO, USA, Aurora

Department of Cardiovascular Sciences, University of Leuven, Leuven

University of Alberta, Edmonton

Vancouver General Hospital, Vancouver

QEII Hospital, Halifax

Hamilton General Hospital, Hamilton

Juravinski Hospital, Hamilton

McMaster University Medical Centre, Hamilton

St. Joseph's Healthcare, Hamilton

The Ottawa Hospital, Ottawa

North York General, Toronto

Toronto General Hospital, Toronto

University of Manitoba, Winnipeg

Maisonneuve-Rosemont, Montreal

Montreal General Hospital, Montreal

Montreal Jewish General Hospital, Montreal

St. Mary's Hospital, Montreal

Department of Anesthesiology, University of Thessaly, Larissa

Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Heart and Stroke Foundation of Canada

OTHER

lead

McMaster University

OTHER

NCT02228798 - Perioperative Anticoagulant Use for Surgery Evaluation Study | Biotech Hunter | Biotech Hunter